Yale University

Publications

Filters: Keyword is Narcotic Antagonists  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
A
B
Khalsa, Jag, Francis Vocci, Frederick Altice, David Fiellin, and Veronica Miller. "Buprenorphine and HIV primary care: new opportunities for integrated treatment." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S169-72. Abstract
Kosten, Thomas R., and David A. Fiellin. "Buprenorphine for office-based practice: consensus conference overview." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 13 Suppl 1 (2004): S1-7. Abstract
Sullivan, Lynn E., and David A. Fiellin. "Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 41, no. 6 (2005): 891-6. Abstract
C
Davis, Corey, Damika Webb, and Scott Burris. "Changing law from barrier to facilitator of opioid overdose prevention." The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics 41 Suppl 1 (2013): 33-6. Abstract
Fiellin, David A., Robert A. Rosenheck, and Thomas R. Kosten. "Coordination of medical care and opioid dependence treatment in primary care: a case report." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 24, no. 1 (2003): 43-6.
D
E
F
H
I
Friedland, Gerald, and David Vlahov. "Integration of buprenorphine for substance-abuse treatment by HIV care providers." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S1-2.
L
M
N
O
P